TWST - Twist Bioscience Corp logo

TWST

Twist Bioscience Corp

Revenue grew 100% of years5Y
Hold

Twist Bioscience manufactures synthetic DNA products, including genes, gene fragments, and oligo pools for applications in therapeutics, diagnostics, agriculture, data storage, and research. It also provides NGS tools and synthetic controls for various viruses.

โš•๏ธ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago โ†’$1,171today

Score Overview

1 Year
Score
Net Growth-76.02%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth14.67%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score5.4
Net Growth10.11%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth226.30%
Rev TrendEvery year
Revenue Consistencyโ€”
All Time
Score
Net Growth-26.98%
Net Trend29%
Net Income Consistency
Rev Growth7x
Rev TrendEvery year
Revenue Consistency

See the full market ranking โ†’

Twist Bioscience Corp fundamental performance

Between 2020 and 2025, revenue grew from $ 90M to $ 376M and net income went from -$ 139M to -$ 77M. Revenue increased in every one of those 5 years; net income in 2.

Twist Bioscience Corp currently holds a 5-year HDB Score of 5.4 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 125.21โ€”
1 Year2025-08-12
$ 27.45356.14%
5 Years2021-08-12
$ 106.9417.08%
All Time2018-10-31
$ 14.008x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 431M-$ 136M$ 166M
2025$ 376M-$ 77M$ 232M
2024$ 312M-$ 208M$ 276M
2023$ 245M-$ 204M$ 336M
2022$ 203M-$ 217M$ 504M
2021$ 132M-$ 152M$ 477M
2020$ 90M-$ 139M$ 290M
2019$ 54M-$ 107M$ 138M

Explore beyond TWST

You're looking at Twist Bioscience Corp. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies